Delivery Order SPE2DB22D3501-SPE2DB25FTR59

Award Date 12/2/24
Potential Completion Date 12/3/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTR59
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $1,242.77 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This specific Delivery Order, with a completion date of December 3, 2024, is for the supply of ADDYI 100 MG TABLET. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant presence in federal healthcare contracting, particularly with the Defense Logistics Agency.

Generated 3/9/25, 12:58 AM